painless gastroenteroscopy
Conditions
Interventions
One:Ciprofol sedation
Sponsors
The First Affiliated Hospital of Yangtze University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Accurate and complete clinical data; 2. Aged 18-65 years, ASA grade I-II, BMI 18-30 kg/m2; 3. No dysfunction of liver and kidney and other important organs, no shock and cardiopulmonary dysfunction; 4. Ability to read and understand; Informed and willing to participate in this study.
Exclusion criteria
Exclusion criteria: 1. Patients with obvious respiratory and circulatory dysfunction and abnormal liver and kidney function before operation; 2. Patients with severe neuropsychiatric diseases; 3. People with infectious diseases; 4. Taking benzodiazepines or opioids intermittently within 1 month or nearly 3 months; 5. Those who are allergic or taboo to benzodiazepines, opioids, propofol, Ciprofol, flumazenil, naloxone and other drugs and their drug components; 6. Patients who are judged to have difficulty in respiratory tract management: modified Mallampati score III or above.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall incidence of adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total dosage of sedative drugs;Wake-up time; | — |
Countries
China
Contacts
Public ContactRui Xia
The First Affiliated Hospital of Yangtze University
Outcome results
None listed